Immune monitoring of SARS-CoV-2-specific T cell and B cell responses in patients with multiple sclerosis treated with ocrelizumab

INTRODUCTION: Since the development of the coronavirus disease (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), there has been significant interest in determining the effectiveness of SARS-CoV-2 vaccines in patients under immunomodulatory or immunosupp...

Descripción completa

Detalles Bibliográficos
Autores principales: Groß-Albenhausen, Elina, Weier, Alicia, Velten, Markus, Heider, Thorsten, Chunder, Rittika, Kuerten, Stefanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10569464/
https://www.ncbi.nlm.nih.gov/pubmed/37841269
http://dx.doi.org/10.3389/fimmu.2023.1254128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10569464/
https://www.ncbi.nlm.nih.gov/pubmed/37841269
http://dx.doi.org/10.3389/fimmu.2023.1254128

Ejemplares similares